Dr Roger Aston (Executive Chairman)

Dr Aston is the founder and former CEO of Mayne Pharma Group and has more than 20 years’ experience in the healthcare and pharmaceutical industries. Dr Aston is currently serving as a director and chairman on several ASX listed biotechnology companies

Interests in Shares and Options

Dr Aston holds 104,782,951 Fully Paid Ordinary Shares and 528,634 Listed Options.

Other Current Directorships (ASX Listed Companies)

Calzada Limited (ASX:CZD), Immuron Limited (ASX:IMC), Oncosil Limited (ASX: OSL) and Regeneus Limited (ASX:RGS)

Previous Directorships (last 3 years) ASX Listed Companies

Neurodiscovery Limited (ASX:NDL), Ascent Pharma Health (ASX: APH), IDT Limited (ASX:IDT); and Mayne Pharma Group Limited (ASX: MYX)